Please ensure Javascript is enabled for purposes of website accessibility
Search
Accessibility Menu

How to Invest in Ozempic

By Rachel Warren – Jun 25, 2025 at 1:30PM | Fact-checked by Frank Bass

Key Points

  • Ozempic, a type 2 diabetes treatment, presents investment opportunities via Novo Nordisk stock.
  • Projected GLP-1 market growth to almost $160 billion by early the 2030s indicates long-term sector potential.
  • Eli Lilly and Viking Therapeutics are other key players in the expanding GLP-1 market, offering diverse investment choices.
Key findings are powered by ChatGPT and based solely off the content from this article. Findings are reviewed by our editorial team. The author and editors take ultimate responsibility for the content.

Our Guides

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.